startquestionstalksour storystories
tagspreviousget in touchlatest

Palantir and Salesforce put software's rebound on trial: AlphaCheck

June 23, 2026 - 20:30

Palantir and Salesforce put software's rebound on trial: AlphaCheck

The recent rally in software stocks is hitting a critical juncture, with two of the sector's biggest names now under the microscope. Palantir Technologies and Salesforce are both struggling to reclaim key price levels, and until they do, the broader software rebound remains unconfirmed. Investors are watching these two names closely because their performance often signals the health of the entire enterprise tech space.

Palantir, known for its data analytics platforms, has seen its stock surge on artificial intelligence hype, but it has yet to break through a stubborn resistance zone that has capped gains for months. Salesforce, the customer relationship management giant, faces a similar wall. Despite cost-cutting measures and a push into AI tools, its shares have failed to hold above a crucial moving average that bulls need to see cleared.

The problem is not just technical. Both companies are dealing with a cautious spending environment. Businesses are still scrutinizing every software contract, prioritizing tools that deliver immediate returns over long-term bets. Until Palantir and Salesforce can show sustained momentum above their respective ceilings, the narrative of a full software recovery is just speculation. For now, the verdict is still out, and the sector's fate hangs on whether these two leaders can finally break through.


MORE NEWS

Meta stock jumps as Wells Fargo raises price target

September 22, 2026 - 00:45

Meta stock jumps as Wells Fargo raises price target

Meta shares surged more than 10 percent during trading after Wells Fargo raised its price target on the stock from $640 to $796. The significant bump in the target price reflects growing confidence...

LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?

September 21, 2026 - 00:49

LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?

LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible...

Why Xenon Pharmaceuticals (XENE) Is Down 32.2% After Pausing Psychiatry Trials Despite Positive NDA Data

September 20, 2026 - 02:49

Why Xenon Pharmaceuticals (XENE) Is Down 32.2% After Pausing Psychiatry Trials Despite Positive NDA Data

Xenon Pharmaceuticals saw its stock drop 32.2 percent after the company paused new enrollment in its Phase 3 trials for major depressive disorder and bipolar depression. The decision came on the...

Nasdaq (NDAQ) Just Made It Harder For Crypto Criminals To Hide

September 19, 2026 - 21:11

Nasdaq (NDAQ) Just Made It Harder For Crypto Criminals To Hide

On September 15, Nasdaq announced that its Verafin unit has partnered with Stablecore to combine traditional banking data with digital asset activity into a single financial crime detection...

read all news
startquestionstalksour storystories

Copyright © 2026 PayTaxo.com

Founded by: Yasmin McGee

tagseditor's choicepreviousget in touchlatest
your datacookie settingsuser agreement